NCT01803594
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- UC Davis, Ragle Human Nutrition Center Davis, California, United States
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,312 public trials
328 recruiting studies
Lipid Metabolism Disorders trial results
NCT00608023
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +19 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Body Positive Inc. Phoenix, Arizona, United States
- Somero, Michael Indio, California, United States
- UCLA School of Medicine Los Angeles, California, United States
NCT00931268
- Conditions
- Atrophy, Lipid Metabolism Disorders, Lipodystrophy, +7 more
- Locations
-
- Henri Mondor Hospital Créteil, France
Completed
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
NCT05245084
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypertension, +5 more
- Locations
-
- H plus Yangji hospital Seoul, South Korea
NCT03640234
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
- Locations
-
Not specified
NCT05555238
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Hanmi Pharmaceutical Company Limited Seoul, South Korea
NCT02729025
- Conditions
- Behavior, Dyslipidemias, Hypercholesterolemia, Autosomal Dominant, 3, +6 more
- Locations
-
- Research Site Miami, Florida, United States
- Research Site Las Vegas, Nevada, United States
- Research Site Mooresville, North Carolina, United States
- Research Site Philadelphia, Pennsylvania, United States
NCT01439880
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Birmingham, Alabama, United States
- Research Site Tucson, Arizona, United States
- Research Site Little Rock, Arkansas, United States
Completed
Eliglustat on Gaucher Disease Type IIIB
NCT03519646
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT03884647
- Conditions
- Alzheimer Disease, Arrhythmias, Cardiac, Atrial Fibrillation, +44 more
- Locations
-
- Diablo Clinical Research Inc. Walnut Creek, California, United States
- Neurotrials Research Atlanta, Georgia, United States
- Clinical Research Center CTI Norwood, Ohio, United States
- Sourasky Tel-Aviv Medical Center Tel Aviv, Center, Israel